Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension
- 17.05.2017
Erschienen in:
- Verfasst von
- Veronika Wetzl
- Svenja Lena Tiede
- Lothar Faerber
- Norbert Weissmann
- Ralph Theo Schermuly
- Hossein Ardeschir Ghofrani
- Henning Gall
- Erschienen in
- Lung | Ausgabe 4/2017
Abstract
Purpose
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) are of particular interest in the remodeling processes of pulmonary hypertension. The aim of this study was to investigate MMP/TIMP ratios of selected biomarkers (MMP2, MMP9, TIMP1, TIMP4) at follow-up examination (V2) and their prognostic value in patients with idiopathic pulmonary arterial hypertension (iPAH).
Methods
Blood samples were taken from iPAH patients during right heart catheterization at diagnosis (V1, from 2003 to 2012) and first follow-up examination (V2). MMP2, MMP9, TIMP1, and TIMP4 plasma levels at V2 were determined by ELISA. Coincident with sample collection hemodynamic, laboratory, and clinical parameters were acquired. Additionally, death and clinical worsening (CW) events were listed until July 2015.
Results
MMP2/TIMP1 and MMP9/TIMP1 did not correlate with hemodynamic and clinical parameters. MMP2/TIMP4 showed a good correlation with mean pulmonary arterial pressure (mPAP), pulmonary vascular resistance, estimated glomerular filtration rate (eGFR), and tricuspid annular plain systolic excursion (TAPSE). MMP9/TIMP4 shows good correlation with mPAP and eGFR. MMP2/TIMP4 showed significant results in the receiver operating characteristics analysis predicting death (AUC = 0.922; p = 0.005) and CW event (AUC = 0.818; p = 0.026). Patients above the cut-off values had a significantly higher probability to die or experience CW, respectively, estimated by log-rank test (p = 0.010 for death; p = 0.032 for CW).
Conclusions
MMP2/TIMP4 ratio was detected as a marker of disease severity and right ventricular function as well as a predictor for survival and time to clinical worsening and therefore might help for guidance of disease progression in iPAH patients at V2.
Anzeige
- Titel
- Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension
- Verfasst von
-
Veronika Wetzl
Svenja Lena Tiede
Lothar Faerber
Norbert Weissmann
Ralph Theo Schermuly
Hossein Ardeschir Ghofrani
Henning Gall
- Publikationsdatum
- 17.05.2017
- Verlag
- Springer US
- Erschienen in
-
Lung / Ausgabe 4/2017
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750 - DOI
- https://doi.org/10.1007/s00408-017-0014-5
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
